Concise Review: Cell Therapy for Critical Limb Ischemia: An Integrated Review of Preclinical and Clinical StudiesMohammad Qadura, David A. Hess, Daniella C. Terenzi et al.|Stem Cells|2017Cited by 205
Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice by a regulatory CD4+CD25+-dependent mechanism and by shifting cytokine production to favor a Th1 responseBraden Waters, David Lillicrap, Mohammad Qadura et al.|Blood|2008Cited by 82
Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A miceMohammad Qadura, David Lillicrap, Braden Waters et al.|Blood|2009Cited by 63
Serum Metabolic Signatures of Chronic Limb-Threatening Ischemia in Patients with Peripheral Artery DiseaseSandi M. Azab, Philip Britz‐McKibbin, Abdelrahman Zamzam et al.|Journal of Clinical Medicine|2020Cited by 62
Endothelial-specific Loss of IFT88 Promotes Endothelial-to-Mesenchymal Transition and Exacerbates Bleomycin-induced Pulmonary FibrosisShweta Singh, Krishna K. Singh, Mohamed Adam et al.|Scientific Reports|2020Cited by 57